✦ LIBER ✦

9147 Bevacizumab and erlotinib as first-line therapy in advanced (stage IIIB/IV) non-squamous non-small-cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression – a multicenter phase II trial of SAKK

✍ Scribed by Zappa, F.; Droege, C.; Betticher, D.; von Moos, R.; Ochsenbein, A.; Stahel, R.; Rauch, D.; Schmid, P.; Mayer, M.; Pless, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab and erlotinib (BE) first-lin

✍ Zappa, Francesco; Droege, Cornelia; Betticher, Daniel; von Moos, Roger; Bubendor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 325 KB

25PD CIRCULATING MICRO-RNA PROFILING IN

✍ Joerger, M.; Baty, F.; Stahel, R.A.; Betticher, D.; von Moos, R.; Pless, M.; Gau 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Randomized Phase IIIb Trial Evaluating t

✍ Cesare Gridelli; Jaafar Bennouna; Javier de Castro; Anne-Marie C. Dingemans; Fra 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 268 KB